Indications
Dogs:Infections of the skin and soft tissues, i.e. superficial and deep pyoderma and wound infections caused by Gram-positive organisms, typically Staphylococcus spp. and Streptococcus spp., and Gram-negative organisms such as Escherichia coli, Pseudomonas spp. and Proteus spp.Infections of the urinary tract caused by Gram-negative bacteria such as enterobacteriaceae, e.g. Escherichia coli, Enterobacter spp., Klebsiella spp. and Proteus spp., Pseudomonas spp., and Gram-positive organisms, typically Staphylococcus spp.Infections of the gingiva and periodontal tissues caused by anaerobic organisms, for example Porphyromonas spp., Prevotella spp.; Fusobacterium spp., Eikenella spp. and capnophilic bacteria such as Capnocytophaga spp.
Cats:Infections of the respiratory tract caused by Gram-negative organisms such as Pasteurella spp., Escherichia coli and Pseudomonas spp., and Gram-positive organisms such as Streptococcus spp. and Staphylococcus spp.
Composition
- Active substance
- pradofloxacin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.